Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04069273
Title Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma (SEQUEL) (SEQUEL)
Acronym SEQUEL
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Harry H Yoon
Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.